These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 23072836

  • 1. Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.
    Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M, Rothman RB, Goldberg SR, Lupica CR, Sitte HH, Brandt SD, Tella SR, Cozzi NV, Schindler CW.
    Neuropsychopharmacology; 2013 Mar; 38(4):552-62. PubMed ID: 23072836
    [Abstract] [Full Text] [Related]

  • 2. Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).
    Marusich JA, Antonazzo KR, Wiley JL, Blough BE, Partilla JS, Baumann MH.
    Neuropharmacology; 2014 Dec; 87():206-13. PubMed ID: 24594476
    [Abstract] [Full Text] [Related]

  • 3. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
    Anneken JH, Angoa-Pérez M, Kuhn DM.
    J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Stereoselective Actions of Methylenedioxypyrovalerone (MDPV) To Inhibit Dopamine and Norepinephrine Transporters and Facilitate Intracranial Self-Stimulation in Rats.
    Kolanos R, Partilla JS, Baumann MH, Hutsell BA, Banks ML, Negus SS, Glennon RA.
    ACS Chem Neurosci; 2015 May 20; 6(5):771-7. PubMed ID: 25688761
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Stereoselective Effects of Abused "Bath Salt" Constituent 3,4-Methylenedioxypyrovalerone in Mice: Drug Discrimination, Locomotor Activity, and Thermoregulation.
    Gannon BM, Williamson A, Suzuki M, Rice KC, Fantegrossi WE.
    J Pharmacol Exp Ther; 2016 Mar 20; 356(3):615-23. PubMed ID: 26769917
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization of 3,4-methylenedioxypyrovalerone discrimination in female Sprague-Dawley rats.
    Thomas AM, Cargile KJ, Lunn JA, Baker LE.
    Behav Pharmacol; 2021 Sep 01; 32(6):524-532. PubMed ID: 34397448
    [Abstract] [Full Text] [Related]

  • 20. Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.
    Cameron KN, Kolanos R, Solis E, Glennon RA, De Felice LJ.
    Br J Pharmacol; 2013 Apr 01; 168(7):1750-7. PubMed ID: 23170765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.